Parata Systems LLC

Parata Systems LLC, doing business as Tcgrx, a subsidiary of Becton, Dickinson and Company, supplies pharmacy automation systems, medication packaging equipment, and maintenance services to federal healthcare agencies as a prime contractor (100% of awards), competing full-and-open without SBA set-aside designations.

Parata Systems operates out of Durham, North Carolina, primarily classified under NAICS 561910 (Packaging and Labeling Services) and NAICS 333414 (Surgical and Medical Instrument Manufacturing), with procurement activity coded predominantly under PSC J065 (Maintenance, Repair, and Rebuilding of Medical, Dental, and Veterinary Equipment) and PSC 6530. The company specializes in medication packaging automation platforms including the ATP2 Automated Tablet Packager, Parata MAX, Parata Mini, Parata Perl Cut and Roll System, TCGRx systems, and related HD Stock dispensing workstations, supported across federal healthcare agencies through maintenance, installation, training, and technical support services. Representative work includes a $4.875 million pharmacy automation maintenance delivery order under the Defense Logistics Agency Troop Support Medical IDIQ (SPE2D1) running through March 2028; a $618.3 thousand full-service five-year maintenance contract with VA VISN 5 for ATP2 pill packaging units and unit-dose verification systems; and a $751.7 thousand five-year sole-source ATP maintenance and licensing agreement with VA VISN 12 for TCG-Rx systems across five medical centers.

Customer concentration sits overwhelmingly with the Defense Logistics Agency (DLA) Troop Support Medical. The top five funding agencies account for 74% of awards by count, with DLA Troop Support Medical dominating at 840 awards and $965.8 million combined potential value—a fifteen-to-one ratio versus the second-place Department of the Army Medical Command (331 awards, $48.2 million). By potential-value ranking, DLA Troop Support Medical accounts for 84% of the $1.15 billion total portfolio, followed by Army Medical Command ($48.2 million), Defense Health Agency ($37 million), VA VISN 12 ($36.7 million), and the Navy Bureau of Medicine and Surgery ($28.5 million). The concentration is strategic and structural: Parata Systems holds the parent $450 million master IDIQ (SPE2D1) with DLA Troop Support Medical, awarded April 8, 2022, extending through March 31, 2032, which serves as the framework for 782 delivery orders spanning equipment, maintenance, and consumable procurements across military treatment facilities and federal healthcare institutions.

Beyond the DLA master vehicle, Parata Systems maintains secondary presence on the Federal Supply Schedule (FSS) V797P4796A with 271 task orders ($54.1 million) and V797D5017E with 21 task orders ($3.5 million), supporting pharmacy automation component and system sales across civilian and military healthcare buyers. The vendor also holds positions on Medical Equipment and Supplies vehicles (69 task orders, $35.5 million) and other federal procurement frameworks. Activity has remained steady year over year—ranging from 109 awards in 2022 to 222 in 2024 to 136 through October 2026—with 41 awards (combined potential value $14.2 million) reaching ultimate completion in the next twenty-four months and therefore subject to recompete exposure.

Parata Systems operates exclusively as a prime contractor with no recorded subcontractor footprint in its federal award portfolio. The vendor delivers its own labor on service and installation work and supplies equipment directly from its own inventory and manufacturing operations; no major subcontractors are named across the representative awards. This posture reflects its role as an original equipment manufacturer and authorized service representative for Parata and related pharmacy automation platforms, rather than a systems integrator or professional-services prime relying on supply chains.

SCI-reported invoiced revenue on federal service contracts above the $150,000 threshold totaled $179 thousand across fiscal years 2022–2025, with $121 thousand in FY2025 and $58 thousand in FY2024. The SCI dataset shows minimal FTE delivery (1.7 FTEs in FY2024, 0.0 in FY2025)—a reflection of SCI's narrow scope, which excludes goods (pharmacy equipment, consumables, and components), maintenance parts, and the bulk of Parata's federal revenue. On those limited SCI-reportable service contracts, median government-paid rates ran at $16.49 per hour, reflecting lower-tier labor roles rather than senior engineering or program-management staffing. No subcontractor hours were reported across the SCI service contracts captured.

Parata Systems' federal work concentrates in medication packaging automation, dispensing workstations, and related equipment supply and maintenance for the military healthcare system and other federal healthcare facilities. The company's sustained presence under the DLA master IDIQ, coupled with direct relationships across VA networks and other federal healthcare agencies, positions it as a specialized provider of proprietary pharmacy automation technologies with limited direct competition for its own platforms and sole-source service authorization model.